ZL-1211 通过增强 ADCC 和激活 NK 细胞介导的炎症在 CLDN18.2 高表达和低表达胃癌模型中表现出强效抗肿瘤活性
ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell-mediated Inflammation in CLDN18.2-High and -Low Expressing Gastric
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell-mediated Inflammation in CLDN18.2-High and -Low Expressing Gastric
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。